Psilocybin-assisted psychotherapy for cancer-related anxiety and depression

Dr Moran Amit - The University of Texas MD Anderson Cancer Center, Houston, USA
Psilocybin-assisted psychotherapy for cancer-related anxiety and depression ( Dr Moran Amit - The University of Texas MD Anderson Cancer Center, Houston, USA )
23 Aug 2023

AOH1996 treatment targeting PCNA shows promise for reoccurring solid tumours

Dr Linda Malkas - City of Hope, Duarte, USA
AOH1996 treatment targeting PCNA shows promise for reoccurring solid tumours ( Dr Linda Malkas - City of Hope, Duarte, USA )
8 Aug 2023

OncoAlert round up July 28th to August 3rd, 2023

Dr Gil Morgan - Executive Director, OncoAlert
OncoAlert round up July 28th to August 3rd, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )
4 Aug 2023

Sudan: Conflict, cancer care, and ripple effects on the region

Dr Nazik Hammad - University of Toronto, Toronto, Canada
Sudan: Conflict, cancer care, and ripple effects on the region ( Dr Nazik Hammad - University of Toronto, Toronto, Canada )
19 Jul 2023

Geriatric oncology in resource-limited settings

Dr Enrique Soto Perez de Celis - National Institute of Medical Sciences, Mexico City, Mexico
Geriatric oncology in resource-limited settings ( Dr Enrique Soto Perez de Celis - National Institute of Medical Sciences, Mexico City, Mexico )
18 Jul 2023

Gynaecological cancer: New targets and immunotherapy developments

Dr Mark Shahin - Jefferson Health, Philadelphia, USA
Gynaecological cancer: New targets and immunotherapy developments ( Dr Mark Shahin - Jefferson Health, Philadelphia, USA )
7 Jul 2023

ASCO 2023: Highlights and analysis

Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada
ASCO 2023: Highlights and analysis ( Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada )
6 Jun 2023

Dostarlimab chemo combination for primary advanced or recurrent endometrial cancer

Prof Matthew Powell - Washington University School of Medicine, Missouri, USA
Dostarlimab chemo combination for primary advanced or recurrent endometrial cancer ( Prof Matthew Powell - Washington University School of Medicine, Missouri, USA )
6 Jun 2023

FolRα-targeting antibody drug conjugate shows promise in recurrent epithelial ovarian cancer

Dr Ana Oaknin - Vall d´Hebron Institute of Oncology, Barcelona, Spain
FolRα-targeting antibody drug conjugate shows promise in recurrent epithelial ovarian cancer ( Dr Ana Oaknin - Vall d´Hebron Institute of Oncology, Barcelona, Spain )
5 Jun 2023

Next-generation selective RET inhibitor shows initial promise with RET-altered solid tumours

Prof Qing Zhou - Guangdong Provincial People’s Hospital, Guangzhou, China
Next-generation selective RET inhibitor shows initial promise with RET-altered solid tumours ( Prof Qing Zhou - Guangdong Provincial People’s Hospital, Guangzhou, China )
5 Jun 2023

Trastuzumab deruxtecan gives strong anti-tumour activity and durable responses in multiple tumour types

Dr Funda Meric-Bernstram - MD Anderson Cancer Center, Houston, USA
Trastuzumab deruxtecan gives strong anti-tumour activity and durable responses in multiple tumour types ( Dr Funda Meric-Bernstram - MD Anderson Cancer Center, Houston, USA )
5 Jun 2023

Optimising cervical cancer care in Nigeria

Prof Don Dizon - Rhode Island Hospital, Rhode Island, USA
Optimising cervical cancer care in Nigeria ( Prof Don Dizon - Rhode Island Hospital, Rhode Island, USA )
25 May 2023